Top Tech Startups in Europe in 2027

Noovid connects brands with a vetted network of creators to produce video ads that drive growth.

Nova helps Fortune 500s and the Global 2,000 minimize SAP complexities by supercharging productivity to reduce consulting hours, drive faster transformations with lower risk, and Clean Core compliance that reduces TCO. Our strength lies in bridging two worlds: the rapidly evolving field of AI and the mission-critical reality of enterprise systems. This combination enables us to deliver revolutionary software solutions. Nova Intelligence is backed by SAP’s venture arm and leading Silicon Valley venture firms, including Accel and Conviction. Built by successful repeat entrepreneurs, AI researcher from Google DeepMind & Meta AI, the co-inventor of SAP HANA & CTO of Accenture SAP Business group, and a former Fortune 25 CIO.

REMA MIND was founded by two physicians, Dr. Jannis Macek and Dr. Alexander Reese, who were tired of a supplement market built on bold promises and influencer hype. So we built the product we'd recommend ourselves: a daily nootropic drink stick, developed by doctors, grounded in clinical research and made in Germany. Our principle: evidence over promises. Every ingredient and every dose had to earn its place through study data. A patent application for our formulation is underway. The hard problem we solve is trust. EU health claim rules are among the strictest in the world, and as physicians we hold ourselves to an even higher bar. So we can't win with louder claims. We win by making science understandable, building community and earning customers who stay. Our audience: senior knowledge workers, cognitive athletes and high-performing women who want to know what they put in their body. Where we are: REMA MIND GmbH was founded in Berlin in 2026, with founders based in Hamburg and Lübeck. Our first batch is produced and we launch in the DACH market in November 2026, direct to consumer with subscriptions and via partners like cafés, co-working spaces, hotels and companies. A caffeine-free version and new flavours are in the pipeline. Funding: backed by the Berlin Startup Scholarship, otherwise fully self-funded with no investors so far. We kept working as doctors to finance the company and built everything ourselves, from formulation and taste to packaging, fulfillment and our shop. Culture: small, hands-on and science-first. We move fast but never cut corners on quality or honesty. And we give back: the commission from our Brain.fm subscription benefit goes to Stiftung Kinder forschen. Want to build a brand people trust because it deserves it? Let's talk.

Axo Longevity is building Europe’s first high-performance longevity platform: deep blood panels (100+ biomarkers, 2x per year), elite athlete benchmarking, and an AI health copilot, all wrapped in a beautiful, consumer-grade product. We target high performers: athletes, founders, operators, and longevity-focus humans. With a €499/year membership that gives them pro-level data, dashboards, and personalized guidance built GDPR-first and ready to scale across Europe. On the clinical side, we have the guidance of a top level sports Dr. Niko Mihic(Real Madrid FC medical advisor) and Andy Walshe, phd (ex Redbull high performance), plus a growing waitlist of performance-driven members, beta users and creator partners.

Nuestro equipo se esfuerza por mejorar el mundo que nos rodea y ayudar a quienes lo necesitan. Contamos historias de personas reales y damos voz a quienes se enfrentan solos a sus problemas. Estamos convencidos de que, uniendo esfuerzos, podremos ayudarnos mutuamente y mejorar la vida de todos aquellos que necesitan ayuda y apoyo. Nuestro proyecto es sin fines de lucro y no tiene como objetivo generar ingresos, pero agradeceremos cualquier ayuda que nos brinden. Pueden ayudarnos a nosotros y a los protagonistas de nuestras publicaciones no solo con dinero, sino también de otras maneras. Si ustedes mismos necesitan apoyo, con mucho gusto contaremos su historia para ayudar a resolver una situación difícil en la vida.